Profil
Petr Kocis has worked as a Vice President-Preclinical Development at Alzheon, Inc. since 2015.
Postes actifs de Petr Kocis
| Sociétés | Poste | Début |
|---|---|---|
| ALZHEON, INC. | Corporate Officer/Principal | 01/01/2015 |
Expériences
Fonctions occupées
Relations
13
Relations au 1er degré
1
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Alzheon, Inc.
 Alzheon, Inc. BiotechnologyHealth Technology Alzheon, Inc. engages in the provision of medical development. It specializes in treatment for brain health, memory, and aging. It offers ALZ-801, an oral small molecule inhibitor of amyloid formation and neurotoxicity with potential to be a therapy for a genetically defined population of patients with or at high risk for Alzheimer's disease and other neurodegenerative disorders. The company was founded by Martin Tolar in June 2013 and is headquartered in Framingham, MA. | Health Technology |
